GLP-2
GLP-2 is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying
Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury
Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19
Gut Hormones and Bone Remodeling in Humans (KS-2)
Clinical Trials (9)
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying
Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury
Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19
Gut Hormones and Bone Remodeling in Humans (KS-2)
Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.
Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9